Identity
- Trade Name
- LIAISON® Control hGH FDA UDI
- Generic Name
- Human growth hormone (HGH) IVD, control FDA UDI
- Model / Reference
- 310341 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 08056771100465 FDA UDI
- GMDN Term
- Human growth hormone (HGH) IVD, control FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Human growth hormone (HGH) IVD, control
LIAISON® Control hGH by Diasorin Inc. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Human growth hormone (HGH) IVD, control.
- GH Control Slides — BIO SB, INC. · Class I
- Validate — LGC Clinical Diagnostics, Inc. · Class I
- IMMULITE® GROWTH HORMONE CVM — SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Diasorin Inc.
Sources (1)
- FDA UDI 8d4a6ace-4b6f-4c3d-9d64-66398942d730 33 fields · synced Jun 1, 2026